Dongsung Pharmaceutical Decides Capital Reduction Under Rehabilitation Plan, Delays Schedule

Decided to cancel 250,000 common shares held by a specific shareholder (Lee) without compensation as part of court-approved rehabilitation plan
Existing cancellation date (May 14, 2026) postponed; new schedule to be announced later
New stock listing date undetermined; will be re-disclosed when fixed
Plans to sequentially issue convertible bonds and corporate bonds with court approval
Board resolution date is the date of court approval for change in effective date of capital reduction

Filing: [Correction of Description] Report on Major Matters (Decision on Capital Reduction)
Company: Dongsung Pharmaceutical (002210)
Submission: Dongsung Pharmaceutical Co., Ltd.
Receipt: 05-14-2026